Q3FY24 results and release. Subdued.
Jubilant Ingrevia has recently inaugurated an innovative facility for Diketene Derivatives in Gajraula, Uttar Pradesh. This plant will significantly enhance the company’s production capacity by adding 2,000 tonnes per annum (tpa) for manufacturing high-value esters.
The expansion into diketene derivatives represents a strategic move by the company to tap into new markets, particularly in the US and EU regions. These derivatives are poised for substantial growth, positioning them as a key segment within the company’s specialty chemicals portfolio.
With this facility,the organisation is not only bolstering its existing offerings but also signalling a shift in strategy towards capturing emerging opportunities in downstream derivatives. The company is committed to further strengthening its presence in this segment, with plans to introduce new derivatives in addition to the existing ones.
This forward-looking approach aligns with the corporation’s long-term strategic objectives, as it aims to build an advanced product portfolio and solidify its position as a leader in the diketene derivatives market. With innovation and expansion at the forefront, the company is poised to capitalise on evolving market trends and deliver value to its customers worldwide.
7 Likes
kindly give the Report details